The deficiency can be fixed if the network’s common stock closing bid price shares are $1 per share or more for at least 10 consecutive business days during the additional compliance period.
All available options, including a reverse stock split, will be considered to resolve the deficiency. The network hopes to reclaim minimum bid price compliance by May 20, 2024. If not achieved, Nutex has received shareholder approval for a reverse stock split execution at least 10 business days prior to May 20, 2024.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
